'''WIN 55,212-2''' is a chemical described as an [[aminoalkylindole]] derivative, which produces effects similar to those of [[cannabinoid]]s such as [[tetrahydrocannabinol]] (THC) but has an entirely different [[chemical structure]].<ref>{{cite journal | last1 = Compton | first1 = DR | display-authors = etal   | year = 1992 | title = Aminoalkylindole Analogs: Cannabimimetic Activity of a Class of Compounds Structurally Distinct from Δ<sup>9</sup>-Tetrahydrocannabinol | url = | journal = Journal of Pharmacology and Experimental Therapeutics | volume = 263 | issue = 3| pages = 1118–1126 }}</ref><ref>{{Cite journal | last1 = Ferraro | first1 = L. | last2 = Tomasini | first2 = M. C. | last3 = Gessa | first3 = G. L. | last4 = Bebe | first4 = B. W. | last5 = Tanganelli | first5 = S. | last6 = Antonelli | first6 = T. | title = The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmission in Rat Cerebral Cortex: An in Vivo and in Vitro Study | doi = 10.1093/cercor/11.8.728 | journal = Cerebral Cortex | volume = 11 | issue = 8 | pages = 728–733 | year = 2001 | pmid =  11459762| pmc = }}</ref><ref>{{Cite journal |pmid= 12228183 |year= 2002 |author= Zhang, Q.|title= In vitro metabolism of R(+)-2,3-dihydro-5-methyl-3-(morpholinyl)methylpyrrolo 1,2,3-de1,4-benzoxazinyl-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist |volume= 30 |issue= 10 |pages= 1077–1086 |journal= Drug metabolism and disposition: the biological fate of chemicals |doi= 10.1124/dmd.30.10.1077 |display-authors=etal}}

 
}}</ref> that has been found to be a potent analgesic<ref>{{Cite journal | last1 = Meng | first1 = I. D. | last2 = Manning | first2 = B. H. | last3 = Martin | first3 = W. J. | last4 = Fields | first4 = H. L. | title = An analgesia circuit activated by cannabinoids | journal = Nature | volume = 395 | issue = 6700 | pages = 381–383 | year = 1998 | doi = 10.1038/26481 | pmid =  9759727| pmc = }}</ref> in a rat model of neuropathic pain.<ref>{{Cite journal | last1 = Herzberg | first1 = U. | last2 = Eliav | first2 = E. | last3 = Bennett | first3 = G. J. | last4 = Kopin | first4 = I. J. | title = The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain | doi = 10.1016/S0304-3940(96)13308-5 | journal = Neuroscience Letters | volume = 221 | issue = 2–3 | pages = 157–160 | year = 1997 | pmid =  9121688| pmc = }}</ref> It activates [[p42 MAP kinase|p42]] and [[p44 MAP kinase|p44]] [[MAP kinase]] via receptor-mediated signaling.<ref>{{Cite journal 

 
WIN 55,212-2 reduces voluntary wheel running in laboratory mice, but with effects that depend on both genetic background and sex.<ref>{{cite journal  |vauthors=Keeney BK, etal |title=Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior |journal=Pharmacology, Biochemistry and Behavior |volume=101 |issue=4 |pages=528–537 |year=2012 |doi=10.1016/j.pbb.2012.02.017}}</ref>
